THALASSOTHERAPIE MEDITERRANEE : revenue, balance sheet and financial ratios

THALASSOTHERAPIE MEDITERRANEE is a French company founded 20 years ago, specialized in the sector Promotion immobilière de logements. Based in PARIS (75006), this company of category PME shows in 2024 a revenue of 474 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-09

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - THALASSOTHERAPIE MEDITERRANEE (SIREN 489219659)
Indicator 2024 2023 2022 2021 2020 2019 2018 2017 2016
Revenue 474 451 € 172 757 € 95 660 € 119 300 € 2 154 794 € 2 107 289 € 2 077 125 € 2 028 428 € 1 987 791 €
Net income -685 553 € -614 467 € -387 782 € -212 999 € 411 028 € -82 763 € -41 539 € -40 071 € -28 163 €
EBITDA 29 347 € -258 535 € -322 332 € -1 085 654 € 1 042 737 € -100 982 € -99 220 € -66 735 € -51 488 €
Net margin -144.5% -355.7% -405.4% -178.5% 19.1% -3.9% -2.0% -2.0% -1.4%

Revenue and income statement

In 2024, THALASSOTHERAPIE MEDITERRANEE achieves revenue of 474 k€. Revenue is declining over the period 2016-2024 (CAGR: -16.4%). Vs 2023, growth of +175% (173 k€ -> 474 k€). After deducting consumption (0 €), gross margin stands at 474 k€, i.e. a rate of 100%. This ratio measures the ability to generate value from commercial activity. EBITDA (= Gross margin - Personnel expenses - Taxes) reaches 29 k€, representing 6.2% of revenue. Positive scissor effect: EBITDA margin improves by +155.8 pts, sign of improved operational efficiency. The operating margin remains fragile, requiring cost vigilance. Net income is negative at -686 k€ (-144.5% of revenue), which will impact equity.

Revenue (2024) ?
Revenue
Definition
Total amount of sales of goods and services made by the company.
Formula
Sales of goods + Sold production

474 451 €

Gross margin (2024) ?
Gross margin
Definition
Difference between revenue and cost of goods sold.
Formula
Revenue - Cost of goods consumed

474 451 €

EBITDA (2024) ?
Gross Operating Surplus (EBITDA)
Definition
Resources generated by current operations, before depreciation and financial expenses.
Formula
Value added - Personnel expenses - Taxes
Interpretation
Positive = profitable activity

29 347 €

EBIT (2024) ?
EBIT (Operating Income)
Definition
Operating income, including depreciation and provisions.
Formula
EBITDA - Depreciation and provisions + Reversals

-471 785 €

Net income (2024) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

-685 553 €

EBITDA margin (2024) ?
EBITDA margin
Definition
Measures the company's operating profitability.
Formula
(EBE / CA) x 100
Interpretation
> 10% : Good profitability
5-10% : Average
< 5% : Low

6.2%

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at -294%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches -48%. Low autonomy: the company heavily depends on external financing (banks, suppliers).

Debt ratio (2024) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

-293.647%

Financial autonomy (2024) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

-48.277%

Cash flow / Revenue (2024) ?
Cash flow / Revenue
Definition
Self-financing capacity relative to revenue.
Formula
(CAF / CA) x 100
Interpretation
The higher the ratio, the more cash the company generates

-39.236%

Repayment capacity (2024) ?
Repayment capacity
Definition
Number of years needed to repay debts with cash flow.
Formula
Financial debt / Cash flow
Interpretation
< 3 years : Excellent
3-5 years : Fair
> 5 years : Warning

-29.066

Asset age ratio (2024) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

83.4%

Solvency indicators evolution
THALASSOTHERAPIE MEDITERRANEE

Sector positioning

Debt ratio
-293.65 2024
2022
2023
2024
Q1: 0.0
Med: 1.6
Q3: 105.23
Excellent

In 2024, the debt ratio of THALASSOTHERAPIE MEDITERR... (-293.65) ranks in the bottom 25% of the sector, which is positive. This ratio measures the weight of debt relative to equity. A low ratio indicates a solid financial structure with little dependence on creditors.

Financial autonomy
-48.28% 2024
2022
2023
2024
Q1: 0.0%
Med: 12.23%
Q3: 54.65%
Average

In 2024, the financial autonomy of THALASSOTHERAPIE MEDITERR... (-48.3%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.

Repayment capacity
-29.07 years 2024
2022
2023
2024
Q1: -4.13 years
Med: 0.0 years
Q3: 1.24 years
Excellent

In 2024, the repayment capacity of THALASSOTHERAPIE MEDITERR... (-29.07) ranks in the bottom 25% of the sector, which is positive. This ratio indicates the number of years needed to repay debt with cash flow. A short capacity reflects controlled debt and good cash generation.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 29.81. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months. The interest coverage ratio (= EBIT / Interest expenses) is 734.3x. Operating income very largely covers interest expenses: high safety margin.

Liquidity ratio (2024) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

29.81

Interest coverage (2024) ?
Interest coverage
Definition
Ability to cover interest charges with operating income.
Formula
EBIT / Interest expenses
Interpretation
> 3 : Comfortable
1.5-3 : Acceptable
< 1.5 : Risk

734.334

Liquidity indicators evolution
THALASSOTHERAPIE MEDITERRANEE

Sector positioning

Liquidity ratio
29.81 2024
2022
2023
2024
Q1: 134.25
Med: 341.1
Q3: 1144.53
Watch -45 pts over 3 years

In 2024, the liquidity ratio of THALASSOTHERAPIE MEDITERR... (29.81) ranks in the bottom 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio below 1 may signal potential cash flow tensions.

Interest coverage
734.33x 2024
2022
2023
2024
Q1: -13.11x
Med: 0.0x
Q3: 2.3x
Excellent +50 pts over 3 years

In 2024, the interest coverage of THALASSOTHERAPIE MEDITERR... (734.3x) ranks in the top 25% of the sector. This ratio indicates how many times operating income covers interest expenses. High coverage means financial charges weigh little on profitability.

Working capital requirement (WCR) and payment terms

Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 0 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 3 days. Favorable situation: supplier credit is longer than customer credit by 3 days. WCR is negative (-41 days): operations structurally generate cash. Notable WCR improvement over the period (-104%), freeing up cash.

Operating WCR (2024) ?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released
Positive = financing needed

-53 575 €

Customer credit (2024) ?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good
45-60j : Average
> 60j : Long

0 j

Supplier credit (2024) ?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow

3 j

Inventory turnover (2024) ?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover

0 j

WCR in days of revenue (2024) ?
WCR in days of revenue
Definition
Expresses working capital requirement in days of revenue.
Formula
(Operating WCR / Revenue) x 360
Interpretation
The fewer days, the better the working capital management

-41 j

WCR and payment terms evolution
THALASSOTHERAPIE MEDITERRANEE

Positioning of THALASSOTHERAPIE MEDITERRANEE in its sector

Comparison with sector Promotion immobilière de logements

Valuation estimate

Based on 80 transactions of similar company sales (all years), the value of THALASSOTHERAPIE MEDITERRANEE is estimated at 68 178 € (range 25 498€ - 178 391€). With an EBITDA of 29 347€, the sector multiple of 1.0x is applied. The price/revenue ratio is 0.28x (conservative valuation). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Medium reliability: estimate to be confirmed with in-depth analysis.

Estimated enterprise value 2024
80 tx
25k€ 68k€ 178k€
68 178 € Range: 25 498€ - 178 391€
NAF 5 all-time

Valuation detail by method

Ajustez les pondérations selon votre analyse

EBITDA Multiple 50%
29 347 € × 1.0x
Estimation 29 446 €
12 160€ - 89 558€
Revenue Multiple 30%
474 451 € × 0.28x
Estimation 132 733 €
47 729€ - 326 449€
How is this estimate calculated?

This estimate is based on the analysis of 80 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Promotion immobilière de logements)

Compare THALASSOTHERAPIE MEDITERRANEE with other companies in the same sector:

Voir toutes les statistiques du secteur Promotion immobilière de logements

Frequently asked questions about THALASSOTHERAPIE MEDITERRANEE

What is the revenue of THALASSOTHERAPIE MEDITERRANEE ?

The revenue of THALASSOTHERAPIE MEDITERRANEE in 2024 is 474 k€.

Is THALASSOTHERAPIE MEDITERRANEE profitable?

THALASSOTHERAPIE MEDITERRANEE recorded a net loss in 2024.

Where is the headquarters of THALASSOTHERAPIE MEDITERRANEE ?

The headquarters of THALASSOTHERAPIE MEDITERRANEE is located in PARIS (75006), in the department Paris.

Where to find the tax return of THALASSOTHERAPIE MEDITERRANEE ?

The tax return of THALASSOTHERAPIE MEDITERRANEE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does THALASSOTHERAPIE MEDITERRANEE operate?

THALASSOTHERAPIE MEDITERRANEE operates in the sector Promotion immobilière de logements (NAF code 41.10A). See the 'Sector positioning' section above to compare the company with its competitors.